Solution of Big R & D Questions
Pharmintel combines clinical and basic science expertise to understand real unmet medical need in disease diagnosis, pathogenesis, treatment & prognosis.
We provide comprehensive understanding of biomarkers which are important for disease diagnosis, prognosis & patient selection for a therapy. We also decipher evolving biomarkers that can be used as surrogate endpoints in clinical trials.
[read more=”Click here to Read More” less=”Read Less”]
Unraveling The Mystery
Thorough review of a therapeutic target/receptor from clinical, basic science & commercial perspective and creating hypothesis that helps in prioritizing most relevant diseases for this target…. radically reducing time and costs in drug development.
We write reports on different therapeutic area pipelines. We provide comparative analysis of all assets which are in different phases of clinical trials, helps in identifying top in-licensing opportunities, future standard of care, potential threats to current blockbusters.
Recent Treatment Trends
Based on recently published clinical trials data, we assess new treatment trends & evaluate how this newly generated data is fulfilling unmet treatment gaps, helps in creating new treatment algorithms & placement of newer drugs.